Irish merger control is entering a new phase with significant implications, particularly for life sciences. In this podcast, Dervla Broderick and Peter Murphy discuss the CCPC’s first call-in of a sub-threshold deal, use of interim measures, and proposed threshold changes, highlighting the need for earlier competition risk assessment and engagement.